surmount-1 tirzepatide non-diabetic obesity trial SURMOUNT Clinical Trials Orals Session Comparative Efficacy and Safety of

Brandon Richland, MD Many people looking for a new way to lose weight have started hearing about oral semaglutide treatment

Your body manufactures it automatically to prevent overeating and maintain metabolic balancebut some people genetically produce less, contributing to weight gain and hunger dysregulation

Dale Prokupek, MD is a board-certified Internist and Gastroenterologist who runs a private practice based in Los Angeles, California

Tirzepatide (Zepbound) is a once-weekly injectable medication that maintains steady therapeutic levels due to its approximately five-day half-life

Humana Medicare and Amerigroup, offering select coverage